Immunochemical localization of protein kinase Cα in the biopsies of human hepatocellular carcinoma

Chinese Journal of Physiology

Volumn 51, Issue 5, 2008, Pages 269-274

  Ying, Tsung Ho ^a,b   Tsai, Jen Hsiang ^c   Wu, Trang Tiau ^b   Tsai, Min Ting ^b   Su, Wei Wen ^d   Hsieh, Yih Shou ^b   Liu, Jer Yuh ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Hepatitis C virus; Patocellular carcinoma; Protein kinase C alpha

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; PROTEIN KINASE C ALPHA;

ADULT; AGED; ARTICLE; BIOPSY; ENZYMOLOGY; FEMALE; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN KINASE C-ALPHA;

EID: 60849104417     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Andrisani, O.M. and Barnabas, S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int. J. Oncol. 15: 373-379, 1999.
2. Baeuerle, P.A. Pro-inflammatory signaling: last pieces in the NF-NB puzzle? Cur. Biol. 8: R19-R22, 1998.
3. Borowski, P., zur Wiesch, J.S., Resch, K., Feucht, H., Laufs, R. and Schmitz, H. Protein kinase C recognizes the protein kinase Abinding motif of nonstructural protein 3 of hepatitis C virus. J. Biol. Chem. 274: 30722-30728, 1999.
4. Brenner, W., Farber, G., Herget, T., Wiesner, C., Hengstler, J.G. and Thuroff, J.W. Protein kinase C is associated with progression of renal cell carcinoma (RCC). Anticancer Res. 23: 4001-4006, 2003.
5. Buckley, A.R., Putnam, C.W., Evans, R., Laird II, H.E., Shah, G.N. and Montgomery, D.W. and Russell, D.H. Hepatic protein kinase C: translocation stimulated by prolactin and partial hepatectomy. Life Sci. 41: 2827-2834, 1987.
6. Choo, Q.L., Richman, K.H., Han, J.H., Berger, K., Lee, C. and Dong, C. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88: 2451-2455, 1991.
7. Craxi, A., Pasqua, P., Giannuoli, G., Di Stefano, R., Simonetti, R.G. and Pagliaro, L. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis. Hepatogastroenterology 31: 55-59, 1984.
8. Cressman, D.E., Greenbaum, L.E., Haber, B.A. and Taub, R. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269: 30429-30435, 1994.
9. Di Bisceglie, A.M. Hepatitis C. Lancet 351: 351-355, 1998.
10. El-Serag, H.B. Hepatocellular carcinoma: An epidemiologic view. J. Clin. Gastroenterol. 35 (Suppl. 2): S72-S78, 2002.
11. Evans, J.D., Cornford, P.A., Dodson, A., Neoptolemos, J.P. and Foster, C.S. Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer. Am. J. Clin. Pathol. 119: 392-402, 2003.
12. Fournier, D.B., Chisamore, M., Lurain, J.R., Rademaker, A.W., Jordan, V.C. and Tonetti, D.A. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Gynecol. Oncol. 81: 366-372, 2001.
13. Ganem, D. and Varmus, H.E. The molecular biology of the hepatitis B viruses. Ann. Rev. Biochem. 56: 651-693, 1987.
14. Gokmen-Polar, Y., Murray, N.R., Velasco, M.A., Gatalica, Z. and Fields, A.P. Elevated protein kinase CFII is an early promotive event in colon carcinogenesis. Cancer Res. 61: 1375-1381, 2001.
15. Hsieh, Y.H., Wu, T.T., Huang, C.Y., Hsieh, Y.S. and Liu, J.Y. Antisense oligonucleotide MZF-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells. Chinese J. Physiol. 50: 9-15, 2007.
16. Hsieh, Y.H., Wu, T.T., Huang, C.Y., Hsieh, Y.S., Hwang, J.M. and Liu, J.Y. p38 MAPK pathway is involved in protein kinase CL-regulated invasion in human hepatocellular carcinoma cells. Cancer Res. 67: 4320-4327, 2007.
17. Hsieh, Y.H., Wu, T.T., Tsai, J.H., Huang, C.Y., Hsieh, Y.S. and Liu, J.Y. PKCLLexpression regulated by Elk-1 and MZF-1 in human HCC cells. Biochem. Biophy. Res. Commun. 339: 217-225, 2006.
18. Hsu, S.L., Chou, Y.H., Yin, S.C. and Liu, J.Y. Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep3B cells. Biochem. J. 333: 57-64, 1998.
19. Kamimura, K., Hojo, H. and Abe, M. Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: Relationship between its expression and prognosis. Pathol. Int. 54: 224-230, 2004.
20. Kato, N., Yoshida, H., Kioko, Ono-Nita, S., Kato, J., Goto, T., Otsuka, M., Lan, K., Matsushima, K., Shiratori, Y. and Ometa, M. Activation of intracellular signaling by hepatitis B and C viruses: Cviral core is the most potent signal inducer. Hepatology 32: 405-412, 2000.
21. Kekule, A.S., Lauer, U., Weiss, L., Luber, B. and Hofschneider, P.H. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361: 742-745, 1993.
22. Kerfoot, C., Huang, W. and Rotenberg, S.A. Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase Cd. J. Histochem. Cytochem. 52: 419-422, 2004.
23. Koivunen, J., Aaltonen, V. and Peltonen, J. Protein kinase C (PKC) family in cancer progression. Cancer Lett. 235: 1-10, 2005.
24. Koren, R., Ben Meir, D., Langzam, L., Dekel, Y., Konichezky, M., Baniel, J., Livne, P.M., Gal, R. and Sampson, S.R. Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate. Oncol. Rep. 11: 321-326, 2004.
25. Langzam, L., Koren, R., Gal, R., Kugel, V., Paz, A., Farkas, A. and Sampson, S.R. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am. J. Clin. Pathol. 116: 377-385, 2001.
26. Lauer, U., Weiss, L., Lipp, M., Hofschneider, P.H. and Kekule, A.S. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 19: 23-31, 1994.
27. Luber, B., Lauer, U., Weiss, L., Hohne, M., Hofschneider, P.H. and Kekule, A.S. The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C. Res. Virol. 144: 311-321, 1993.
28. Musashi, M., Ota, S. and Shiroshita, N. The role of protein kinase C isoforms in cell proliferation and apoptosis. Int. J. Hematol. 72: 12-19, 2000.
29. Neill, G.W., Ghali, L.R., Green, J.L., Ikram, M.S., Philpott, M.P. and Quinn, A.G. Loss of protein kinase Caaexpression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. Cancer Res. 63: 4692-4697, 2003.
30. Niedel, J.E. and Blackshear, P.J. Protein kinase C. In: Phosphoinositides and Receptor Mechanisms, edited by Putney, J.W. New York, NY: Alan R. Liss Inc., 1986, pp. 47-88.
31. Nishizuka, Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1988.
32. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698, 1987.
33. Su, Q., Schroder, C.H., Hofmann, W.J., Otto, G., Pichlmayr, R. and Bannasch, P. Expression of hepatitis B virus X protein in HBVinfected human livers and hepatocellular carcinomas. Hepatology 27: 1109-1120, 1998.
34. Tai, D.I., Tsai, S.L., Chen, Y.M., Chuang, Y.L., Peng, C.Y. and Sheen, I.S. Activation of nuclear factor SSin hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31: 656-664, 2000.
35. Tsai, J.H., Tsai, M.T., Su, W.W., Chen, Y.L., Wu, T.T., Hsieh, T.H., Huang, C.Y., Yeh, K.T. and Liu, J.Y. Expression of protein kinase Ckkin biopsies and surgical specimens of human hepatocellular carcinoma. Chinese J. Physiol. 48: 139-143, 2005.
36. Varga, A., Czifra, G., Tallai, B., Nemeth, T., Kovacs, I., Kovacs, L. and Biro, T. Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. Eur. Urol. 46: 462-465, 2004.
37. Weichert, W., Gekeler, V., Denkert, C., Dietel, M. and Hauptmann, S. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis. Int. J. Oncol. 23: 633-639, 2003.
38. Wetsel, W.C., Khan, W.A., Merchenthaler, I., Rivera, H., Halpern, A.E., Phung, H.M., Negro-Vilar, A. and Hannun, Y.A. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J. Cell Biol. 117: 121-133, 1992.
39. Wu, T.T., Hsieh, Y.H., Hsieh, Y.S. and Liu, J.Y. Reduction of PKCPPdecreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J. Cell. Biochem. 103: 9-20, 2008.
40. Wu, T.T., Hsieh, Y.H., Wu, C.C., Hsieh, Y.S., Huang, C.Y. and Liu, J.Y. Overexpression of protein kinase CvvmRNA in human hepatocellular carcinoma: a potential marker of disease prognosis. Clin. Chim. Acta 382: 54-58, 2007.